Concurrent Liver Lesions in Patients with HIV-Associated Tuberculosis: Approaches to Therapy

The objective: to evaluate efficacy of treatment of concurrent (viral and drug-induced) liver injuries in patients with HIV-associated tuberculosis using a multicomponent solution for infusions containing succinic acid.

Subjects and Methods. The prospective comparative study included 122 patients with HIV-associated tuberculosis and concurrent chronic hepatitis C and B, distributed in 3 groups depending on the clinical and biochemical activity of (viral and drug-induced) liver injuries and the nature of therapy. Group 1 included 48 patients with minimal activity of concurrent liver injury, Group 2 included 38 patients, and Group 3 included 36 patients with moderate clinical and biochemical activity. Patients in Groups 1 and 2 received intravenous administration of the solution of inosine + meglumine + methionine + nicotinamide + succinic acid (Remaxol, OOO NTFF POLYSAN) for 10 days, in Group 3, patients had detoxification therapy (glucose-saline solutions, sterofundin) and ursodeoxycholic acid.

Results. Against the background of infusions of the solution of inosine + meglumine + methionine + nicotinamide + succinic acid in patients of Groups 1 and 2 there was a more pronounced decrease of ALT in 3.6-3.8 times vs. 1.9; AST – in 2.6-2.7 times vs. 2.4; TB – in 3.7 times vs. 1.6; DB – in 3.3 times vs. 1.8; GGT – in 5.7 times vs. 4.9 in Group 3.

Conclusion. The obtained results demonstrate the efficacy of the solution of inosine + meglumine + methionine + nicotinamide + succinic acid in treatment of concurrent (viral and drug-induced) liver injuries with minimal and moderate clinical and biochemical activity in patients with HIV-associated tuberculosis.

1. Azovtseva O.V., Panteleev A.M., Karpov A.V., Arkhipov G.S., Weber V.R., Belyakov N.A., Arkhipova E.I. Analysis of medical and social factors affecting the formation and course of co-infection HIV, tuberculosis and viral hepatitis. Russian Journal of Infection and Immunity, 2019, vol. 9, no. 5-6, pp. 787-799. (In Russ.) https://doi.org/10.15789/2220-7619-2019-5-6-787-799

2. Asratyan A.A., Semenenko T.A., Kalnin I.B., Orlova O.A., Soloviev D.V., Rusakova E.V., Kazaryan S.M., Kuzin S.N. Current epidemiological features of viral hepatitis B and C, tuberculosis and HIV infection in psychiatric hospitals. Journal of Microbiology, Epidemiology and Immunobiology, 2020, vol. 97, no. 1, pp. 32-39. (In Russ.) https://doi.org/10.36233/0372-9311-2020-97-1-32-39

3. Belyakov N.A., Boeva E.V., Zagdyn Z.M., Esaulenko E.V., Lioznov D.A., Simakina O.E. Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis C and tuberculosis. Russian Journal of Infection and Immunity, 2022, vol. 12, no. 4, pp. 639-650. (In Russ.) https://doi.org/10.15789/2220-7619-EAC-1958

4. Vetushko D.A., Zhavoronok S.V., Glinskaya T.N., Skryagina E.M. HIV infection, drug-resistant tuberculosis and viral hepatitis C: approaches to management of patients with coinfection. Gepatologiya i Gastroenterologiya, 2022, no. 2, pp. 146. (In Russ.)

5. Ivashkin V.T., Baranovskiy A.Yu., Raykhelson K.L., Palgova L.K., Maevskaya M.V., Kondrashina E.A., Marchenko N.V., Nekrasova T.P., Nikitin I.G. Drug-induced liver injuries (clinical guidelines for physicians). Russian Journal of Gastroenterology, Hepatology, Coloproctology, 2019, vol. 29, no. 1, pp. 101-131. (In Russ.) https://doi.org/10.22416/1382-4376-2019-29-1-101-131

6. Kukurika A.V. Predictors of unfavorable treatment outcomes for HIV-associated MDR-TB in patients with viral hepatitis C. Journal Infectology, 2024, vol. 16, no. 2, pp. 81-88. (In Russ.) https://doi.org/10.22625/2072-6732-2024-16-2-81-88

7. Kurganova T.Yu., Melnikova T.N., Kovalev N.Yu., Ogurtsova S.V., Simakina O.E., Zagdyn Z.M., Belyakov N.A. Epidemiology of three coinfections: HIV, viral hepatitis and tuberculosis in the Vologda region as a model of infection development in the Northwestern Federal District. HIV Infection and Immunosuppressive Disorders, 2021, vol. 13, no. 1, pp. 7-16. (In Russ.) https://doi.org/10.22328/2077-9828-2021-13-1-7-16

8. Lekarstvennyye porazheniya pecheni u vzroslykh: klinicheskiye rekomendatsii. [Drug-induced liver injury in adults: clinical guidelines]. Russian Scientific Medical Society of General Practitioners, Russian Scientific Society of Gastroenterologists, Moscow, 2022, 39 p.

9. Matievskaya N.V., Kashevnik T.I., Kopitskiy A.V., Skazka A.E. Age and gender aspects of HIV-infected patients mortality. HIV Infection and Immunosuppressive Disorders, 2020, vol. 12, no. 4, pp. 51-59. (In Russ.) https://doi.org/10.22328/2077-9828-2020-12-4-51-59

10. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiyskoy Federatsii v 2023 year. Gosudarstvenny doklad. [State report on the state on sanitary and epidemiological welfare of population in the Russian Federation in 2023]. Moscow, Federalnaya Sluzhba po Nadzoru v Sfere Zaschity Prav Potrebiteley i Blagopoluchiya Cheloveka Publ., 2024, 364 p.

11. Salina T.Yu., Morozova T.I. Clinical manifestations and treatment efficiency of those suffering from TB/HIV co-infection infection and hepatitis. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 9, pp. 25-29. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-9-25-29

12. Sindrom tsitoliza. [Cytolysis syndrome]. Available: https://reclin.ru/wp-content/uploads/2024/06/sindrom-czitoliza.pdf?ysclid=m5jfe3831r503326858 Accessed December 30, 2024

13. Tuberkulez u vzroslykh. Klinicheskie rekomendatsii [Tuberculosis in adults: Guidelines]. Russian Phthisiologists' Society, National Association of Non-profit Organizations of Phthisiologists Association of Phthisiologists, Moscow, 2022, 112 p.

14. Tuberkulez u vzroslykh. Klinicheskie rekomendatsii. [Tuberculosis in adults: Guidelines]. All-Russia Non-Commercial Organization of the Russian Society of Phthisiologists, National Association of Non-profit Organizations of Phthisiologists Association of Phthisiologists, Moscow, 2024, 167 p.

15. Entsiklopediya lekarstvennykh preparatov RLS. [Encyclopedia of medicinal products RLS]. 2024. Available: https://www.rlsnet.ru/ Accessed November 4, 2024

16. Gedefie A., Seid A., Molla Fenta G., Tilahun M., Shibabaw A., Ali A. Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study. SAGE Open Med., 2023, no. 11, pp. 20503121231166642. https://doi.org/10.1177/20503121231166642

17. World Health Organization. Global tuberculosis report. Geneva, World Health Organization. WHO, 2023. Available: Https://www.who.int/publications/i/item/9789240083851 Аccessed October 15, 2024